Washington Law Review
Abstract
This Article considers the many barriers that health-care providers and public health authorities face in stemming the modem TB epidemic. Part II reviews historical public health measures, their results, and their adaptability to resurgent and MDR-TB. Part III considers the fundamental barriers to a successful global effort using these public health strategies, concluding that these barriers are insurmountable given the current arsenal of anti-tuberculosis therapies. Part IV examines the reasons why research and development of new anti-tuberculosis drugs and vaccines have stagnated over the last quarter century. Finally, part V explores incentives that might revive research and development of such therapies and thus tip the scales toward control of this dangerous new white plague.
First Page
919
Recommended Citation
Patricia C. Kuszler,
Symposium,
Balancing the Barriers: Exploiting and Creating Incentives to Promote Development of New Tuberculosis Treatments,
71 Wash. L. Rev.
919
(1996).
Available at:
https://digitalcommons.law.uw.edu/wlr/vol71/iss4/3